Abstract
Infections in pregnancy may lead to fetal morbidity and mortality. The major infections which can be transmitted from the mother to the fetus and can probably result in adverse consequences in the prenatal period include toxoplasmosis, rubella, cytomegalovirus (CMV), syphilis, parvovirus, and varicella. Factors determining the risks of transplacental transmission and associated fetal adverse events include the period of gestation at which transmission occurs and the immunity status of the mother. No single modality can diagnose all fetal infections and consequently prenatal diagnosis of fetal manifestations of infections is frequently made by fetal sonography and serology to identify the specific infectious agent. Ultrasound is now considered the safest and least invasive primary tool for the detection and monitoring of antenatal infection. Major findings in cases of fetal infection are observed in the central nervous system and heart with parenchymal calcifications, pleural/pericardial effusions, ascites, fetal growth restriction, oligo-/polyhydramnios and placentomegaly being frequently seen. Various diagnostic interventions are also performed under ultrasound guidance such as amniocentesis to determine underlying etiology and cordocentesis to detect fetal anemia. Knowledge of the various diagnostic modalities is required for appropriate counseling of the couple and for optimal treatment.
Similar content being viewed by others
References
Bailão LA, Osborne NG, Rizzi MC, Bonilla-Musoles F, Duarte G, Bailão TC. Ultrasound markers of fetal infection part 1: viral infections. Ultrasound Q. 2005;21(4):295–308.
Bailao ND, Rizzi MC, Bonila-Musoles F, et al. Ultrasound markers of fetal infection: an update. Ultrasound Q. 2000;16(4):221–33.
Ghidini A, Lynch L. Prenatal diagnosis and significance of fetal infections, in fetal medicine [special issue]. West J Med. 1993;159:366–73.
Dontigny L, Arsenault MY, Martel MJ. Rubella in pregnancy. SOGC clinical practice guidelines. J Obstet Gynaecol Can. 2008;30(2):152–8.
Best JM. Rubella. Semin Fetal Neonatal Med. 2007;12:182–92.
Tang JW, Aarons E, Hesketh LM, Strobel S, Schalasta G, Jauniaux E, Brink NS, Enders G. Prenatal diagnosis of congenital rubella infection in the second trimester of pregnancy. Prenat Diagn. 2003;23(6):509–12.
Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–76.
American College of Obstetricians and Gynecologists. Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol. 2015;125(6):1510–25.
Guerra B, Simonazzi G, Puccetti C, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol. 2008;198(380):380.e1–7.
Khalil A, Heath P, Jones C, Soe A, Ville YG, on behalf of the Royal College of Obstetricians and Gynaecologists. Congenital cytomegalovirus infection: update on treatment. Scientific impact paper no. 56. BJOG. 2018;125:e1–11.
Cytomegalovirus in pregnancy. SOGC clinical practice guidelines. No 240, 2018 February. J Obstet Gynaecol Can. 2018;40(2):e134–41.
Enders G, Daiminger A, Bäder U, Exler S, Schimpf Y, Enders M. The value of CMV IgG avidity and immunoblot for timing the onset of primary CMV infection in pregnancy. J Clin Virol. 2013;56(2):102–7.
Yinon Y, Farine D, Yudin MH. Screening, diagnosis, and management of cytomegalovirus infection in pregnancy. Obstet Gynecol Surv. 2010;65(11):736–43.
Harger JH, Ernest JM, Thurnau GR, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis. 2002;185:422–7.
Management of varicella infection in pregnancy. SOGC clinical guidelies. No. 274 August 2018. J Obstet Gynaecol Can. 2018;40(8):e652–7.
Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17:1–13.
Wald A, Huang M-L, Carrel D, Selke S, Corey L. Polymerase chain reaction for herpes simplex virus DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis. 2003;188:1345–51.
de Jong EP, de Haan TR, Kroes AC, et al. Parvovirus B19 infection in pregnancy. J Clin Virol. 2006;36:1.
Young NS, Brown KE. Parvovirus B19. N Engl J Med. 2004;350(6):586–97.
Yaegashi N. Pathogenesis of nonimmune hydrops fetalis caused by intrauterine B19 infection. Tohoku J Exp Med. 2000;190:65–82.
Parvo virus infection in pregnancy. SOGC Clinical guidelines. No. 316 August 2014. J Obstet Gynaecol Can. 2014;36(12):1107–16.
Dunn D, Wallon M, Peyron F, Peterson E, Peckhem C, Gilbert R. Mother to child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet. 1999;353:1–33.
Toxoplasmosis in pregnancy: prevention, screening and treatment. SOGC clinical guidelines. No. 285 January 2013. J Obstet Gynaecol Can. 2013;35(1):78–9.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rana, A., Sharma, K.A. Diagnosis of Infections in Fetus: Ultrasound and Invasive Techniques. J. Fetal Med. 7, 243–252 (2020). https://doi.org/10.1007/s40556-020-00259-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40556-020-00259-2